Published in Gut on October 01, 2001
Insights into the pathobiology of hepatitis C virus-associated cirrhosis: analysis of intrahepatic differential gene expression. Am J Pathol (2002) 1.34
The coagulation system contributes to alphaVbeta6 integrin expression and liver fibrosis induced by cholestasis. Am J Pathol (2010) 1.21
β-Catenin Signaling and Roles in Liver Homeostasis, Injury, and Tumorigenesis. Gastroenterology (2015) 1.20
Switch from Mnt-Max to Myc-Max induces p53 and cyclin D1 expression and apoptosis during cholestasis in mouse and human hepatocytes. Hepatology (2009) 1.12
Gene expression profiling of alcoholic liver disease in the baboon (Papio hamadryas) and human liver. Am J Pathol (2003) 1.08
Angiogenic cell therapy for hepatic fibrosis. Med Mol Morphol (2006) 0.97
Primary biliary cirrhosis: what we know and what we want to know about human PBC and spontaneous PBC mouse models. J Gastroenterol (2007) 0.94
An intravital microscopic study of the hepatic microcirculation in cirrhotic mice models: relationship between fibrosis and angiogenesis. Int J Exp Pathol (2008) 0.93
Plasma cells and the chronic nonsuppurative destructive cholangitis of primary biliary cirrhosis. Hepatology (2012) 0.91
Lymphocyte recruitment and homing to the liver in primary biliary cirrhosis and primary sclerosing cholangitis. Semin Immunopathol (2009) 0.91
Identification of Cd101 as a susceptibility gene for Novosphingobium aromaticivorans-induced liver autoimmunity. J Immunol (2011) 0.90
β-catenin is overexpressed in hepatic fibrosis and blockage of Wnt/β-catenin signaling inhibits hepatic stellate cell activation. Mol Med Rep (2014) 0.90
Pathway-based analysis of primary biliary cirrhosis genome-wide association studies. Genes Immun (2013) 0.90
Genomics and proteomics in liver fibrosis and cirrhosis. Fibrogenesis Tissue Repair (2012) 0.90
Novel aspects of the liver microenvironment in hepatocellular carcinoma pathogenesis and development. Int J Mol Sci (2014) 0.89
Activation of sonic hedgehog signaling pathway is an independent potential prognosis predictor in human hepatocellular carcinoma patients. Chin J Cancer Res (2012) 0.88
Chronic expression of interferon-gamma leads to murine autoimmune cholangitis with a female predominance. Hepatology (2016) 0.86
Epidermal growth factor protects the apical junctional complexes from hydrogen peroxide in bile duct epithelium. Lab Invest (2011) 0.84
The hepatic transcriptome in human liver disease. Comp Hepatol (2006) 0.82
Wnt5a participates in hepatic stellate cell activation observed by gene expression profile and functional assays. World J Gastroenterol (2012) 0.81
The immunology of primary biliary cirrhosis: the end of the beginning? Clin Exp Immunol (2002) 0.81
Role of Notch signaling in regulating innate immunity and inflammation in health and disease. Protein Cell (2016) 0.81
Hepatocyte produced matrix metalloproteinases are regulated by CD147 in liver fibrogenesis. PLoS One (2014) 0.80
Impact of microbes on autoimmune diseases. Arch Immunol Ther Exp (Warsz) (2013) 0.80
TGF-β1 and TGF-β2 abundance in liver diseases of mice and men. Oncotarget (2016) 0.78
Anchoring hepatic gene expression with development of fibrosis and neoplasia in a toxicant-induced fish model of liver injury. Toxicol Pathol (2012) 0.76
Autoimmune disease triggered by infection with alphaproteobacteria. Expert Rev Clin Immunol (2009) 0.75
Gene expression profiles of peripheral blood mononuclear cells in primary biliary cirrhosis. Clin Exp Med (2014) 0.75
Hepatocyte Turnover in Chronic HCV-Induced Liver Injury and Cirrhosis. Gastroenterol Res Pract (2015) 0.75
Total parenteral nutrition leads to alteration of hepatocyte cell cycle gene expression and proliferation in the mouse. Dig Dis Sci (2007) 0.75
Role of the autonomic nervous system in rat liver regeneration. Cell Mol Neurobiol (2011) 0.75
Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A (1998) 192.97
Quantification of low-copy transcripts by continuous SYBR Green I monitoring during amplification. Biotechniques (1998) 11.39
Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem (2000) 9.07
Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1. Nat Genet (1997) 6.66
Connective tissue growth factor: a mediator of TGF-beta action on fibroblasts. Cytokine Growth Factor Rev (1997) 3.86
TAFII250-dependent transcription of cyclin A is directed by ATF activator proteins. Genes Dev (1997) 3.40
The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily. Cancer Res (1995) 3.04
Notch activity influences the alphabeta versus gammadelta T cell lineage decision. Cell (1997) 2.66
Chemokine and chemokine receptor interactions provide a mechanism for selective T cell recruitment to specific liver compartments within hepatitis C-infected liver. J Immunol (1999) 2.61
Dishevelled: at the crossroads of divergent intracellular signaling pathways. Mech Dev (1999) 2.51
Class VI intermediate filament protein nestin is induced during activation of rat hepatic stellate cells. Hepatology (1999) 2.45
An activated form of Notch influences the choice between CD4 and CD8 T cell lineages. Cell (1996) 2.42
Mesenchymal to epithelial conversion in rat metanephros is induced by LIF. Cell (1999) 2.04
Promoter-selective transcriptional defect in cell cycle mutant ts13 rescued by hTAFII250. Science (1994) 2.02
Increased expression of monocyte chemotactic protein-1 during active hepatic fibrogenesis: correlation with monocyte infiltration. Am J Pathol (1998) 2.01
Expression of connective tissue growth factor in experimental rat and human liver fibrosis. Hepatology (1999) 1.94
Role of members of the Wnt gene family in human hematopoiesis. Blood (1998) 1.86
Fibroblast activation protein: a cell surface dipeptidyl peptidase and gelatinase expressed by stellate cells at the tissue remodelling interface in human cirrhosis. Hepatology (1999) 1.84
Signal transduction by the neurotrophin receptors. Curr Opin Cell Biol (1997) 1.83
Expression and function of wingless and frizzled homologs in rheumatoid arthritis. Proc Natl Acad Sci U S A (2000) 1.81
Stimulation of matrix metalloproteinase production by recombinant extracellular matrix metalloproteinase inducer from transfected Chinese hamster ovary cells. J Biol Chem (1997) 1.69
GDNF family neurotrophic factor signaling: four masters, one servant? Mol Cell Neurosci (1999) 1.59
Immunohistochemical characterization of hepatic lymphocytes in primary biliary cirrhosis in comparison with primary sclerosing cholangitis and autoimmune chronic active hepatitis. Mayo Clin Proc (1993) 1.59
Nerve growth factor is an autocrine survival factor for memory B lymphocytes. Cell (1996) 1.57
Cellular mechanisms of wingless/Wnt signal transduction. Curr Top Dev Biol (1999) 1.55
Transforming growth factors beta 1 and beta 2 are differentially expressed in fibrotic liver disease. Am J Pathol (1991) 1.55
Notch signalling pathway and human diseases. Semin Cell Dev Biol (1998) 1.52
Primary biliary cirrhosis: an orchestrated immune response against epithelial cells. Immunol Rev (2000) 1.50
Human biliary epithelial cells secrete and respond to cytokines and hepatocyte growth factors in vitro: interleukin-6, hepatocyte growth factor and epidermal growth factor promote DNA synthesis in vitro. Hepatology (1994) 1.49
Hepatic stellate cells express the low affinity nerve growth factor receptor p75 and undergo apoptosis in response to nerve growth factor stimulation. Am J Pathol (2000) 1.39
Role of nerve growth factor in a mouse model of allergic airway inflammation and asthma. Eur J Immunol (1998) 1.37
Expression of nerve growth factor and nerve growth factor receptor tyrosine kinase Trk in activated CD4-positive T-cell clones. Proc Natl Acad Sci U S A (1993) 1.33
Follistatin: a multifunctional regulatory protein. Front Neuroendocrinol (1998) 1.29
Activin induces cell death in hepatocytes in vivo and in vitro. Hepatology (1993) 1.25
In situ nucleic acid hybridization of cytokines in primary biliary cirrhosis: predominance of the Th1 subset. Hepatology (1997) 1.20
Activin A: an autocrine inhibitor of initiation of DNA synthesis in rat hepatocytes. J Clin Invest (1993) 1.18
Evidence for the targeting by 2-oxo-dehydrogenase enzymes in the T cell response of primary biliary cirrhosis. J Immunol (1991) 1.17
Reactivity of primary biliary cirrhosis sera with Escherichia coli dihydrolipoamide acetyltransferase (E2p): characterization of the main immunogenic region. Proc Natl Acad Sci U S A (1990) 1.17
Profiling of differentially expressed genes in human primary cervical cancer by complementary DNA expression array. Clin Cancer Res (1998) 1.15
Tumor-derived EMMPRIN (extracellular matrix metalloproteinase inducer) stimulates collagenase transcription through MAPK p38. FEBS Lett (1998) 1.12
Human intrahepatic biliary epithelial cells proliferate in vitro in response to human hepatocyte growth factor. J Clin Invest (1992) 1.12
Synaptophysin: A novel marker for human and rat hepatic stellate cells. Am J Pathol (1999) 1.11
Heterogeneity of autoreactive T cell clones specific for the E2 component of the pyruvate dehydrogenase complex in primary biliary cirrhosis. J Exp Med (1995) 1.11
Molecular pathogenesis of liver disease: an approach to hepatic inflammation, cirrhosis and liver transplant tolerance. Immunol Rev (2000) 1.11
Molecular mimicry in primary biliary cirrhosis. Evidence for biliary epithelial expression of a molecule cross-reactive with pyruvate dehydrogenase complex-E2. J Clin Invest (1993) 1.09
A possible role for the high mobility group box transcription factor Tcf-4 in vertebrate gut epithelial cell differentiation. J Biol Chem (1999) 1.09
Hepatic jagged1 expression studies. Hepatology (1999) 1.05
Progressive development of a Th1-type hepatic cytokine profile in rats with experimental cholangitis. Hepatology (2000) 1.05
Immediate onset of DNA synthesis in remnant rat liver after 90% hepatectomy by an administration of follistatin. J Hepatol (1998) 1.04
Increased intrahepatic messenger RNA expression of interleukins 2, 6, and 8 in human cirrhosis. Gastroenterology (1994) 1.02
Human keratinocytes express EMMPRIN, an extracellular matrix metalloproteinase inducer. J Invest Dermatol (1996) 1.01
A single intraportal administration of follistatin accelerates liver regeneration in partially hepatectomized rats. Gastroenterology (1995) 0.97
Analysis of hepatic T lymphocyte and immunoglobulin deposits in patients with primary biliary cirrhosis. Hepatology (1990) 0.96
Control of digit formation by activin signalling. Development (1999) 0.95
Antisense TR3 orphan receptor can increase prostate cancer cell viability with etoposide treatment. Endocrinology (1998) 0.94
Cytokines in primary biliary cirrhosis. Semin Liver Dis (1997) 0.93
Autoreactive responses to pyruvate dehydrogenase complex in the pathogenesis of primary biliary cirrhosis. Immunol Rev (2000) 0.93
Breakdown of tolerance to pyruvate dehydrogenase complex in experimental autoimmune cholangitis: a mouse model of primary biliary cirrhosis. Hepatology (1999) 0.92
Activin A regulates growth and acute phase proteins in the human liver cell line, HepG2. Mol Cell Endocrinol (1999) 0.92
Application of the differential hybridization of Atlas Human expression arrays technique in the identification of differentially expressed genes in human glioblastoma multiforme tumor tissue. J Surg Oncol (1998) 0.91
Graded amounts of Xenopus dishevelled specify discrete anteroposterior cell fates in prospective ectoderm. Mech Dev (1997) 0.91
Ductular expression of autoantigens in primary biliary cirrhosis. Semin Liver Dis (1997) 0.90
Mitochondrial antigens, molecular mimicry and autoimmune disease. Biochim Biophys Acta (1995) 0.90
The role of activin and transforming growth factor-beta in the regulation of organ mass in the rat liver. Hepatology (2000) 0.89
The peculiar autoimmunity of primary biliary cirrhosis. Immunol Rev (2000) 0.87
Signal transduction by the receptor tyrosine kinase Ret. Recent Results Cancer Res (1998) 0.86
TGF-beta isoforms in alcoholic liver disease. J Gastroenterol (1998) 0.86
Enzyme inhibitory autoantibodies to pyruvate dehydrogenase complex in primary biliary cirrhosis differ for mammalian, yeast and bacterial enzymes: implications for molecular mimicry. Hepatology (1994) 0.84
Mechanisms of development of multiple endocrine neoplasia type 2 and Hirschsprung's disease by ret mutations. Recent Results Cancer Res (1998) 0.84
Cell-kinetic study of proliferating bile ductules in various hepatobiliary diseases. Liver (1998) 0.83
A DNA chip off the aging block. Nat Med (2000) 0.83
Regulation of the expression of follistatin in rat hepatocytes. Biochim Biophys Acta (1997) 0.82
Transforming growth factor betas and their receptors in human liver cirrhosis. Eur J Gastroenterol Hepatol (1998) 0.82
T cell responses to the putative dominant autoepitope in primary biliary cirrhosis (PBC). Clin Exp Immunol (1999) 0.81
Cell surface immunophenotype and gelatinase activity of the human breast carcinoma cell line (MCF-7/6) with functionally defective E-cadherin. Neoplasma (1999) 0.78
Nestin in the liver--lessons from the brain. Hepatology (1999) 0.76
Periacinar stellate shaped cells in rat pancreas: identification, isolation, and culture. Gut (1998) 3.77
Pancreatic stellate cells are activated by proinflammatory cytokines: implications for pancreatic fibrogenesis. Gut (1999) 3.36
Corneal confocal microscopy: a non-invasive surrogate of nerve fibre damage and repair in diabetic patients. Diabetologia (2003) 2.45
Asian Pacific Association for the Study of the Liver consensus statements on the diagnosis, management and treatment of hepatitis C virus infection. J Gastroenterol Hepatol (2007) 2.35
Activation of pancreatic stellate cells in human and experimental pancreatic fibrosis. Am J Pathol (1999) 2.12
Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines. Hepatology (1996) 2.01
Terlipressin therapy for moderate-to-severe hyponatraemia in patients with liver failure. Intern Med J (2013) 2.00
Systematic review of role of polymerase chain reaction in defining infectiousness among people infected with hepatitis C virus. BMJ (1997) 1.92
Real-time reverse transcriptase-polymerase chain reaction (RT-PCR) for measurement of cytokine and growth factor mRNA expression with fluorogenic probes or SYBR Green I. Immunol Cell Biol (2001) 1.85
Fibroblast activation protein: a cell surface dipeptidyl peptidase and gelatinase expressed by stellate cells at the tissue remodelling interface in human cirrhosis. Hepatology (1999) 1.84
Regulation of the receptor specificity and function of the chemokine RANTES (regulated on activation, normal T cell expressed and secreted) by dipeptidyl peptidase IV (CD26)-mediated cleavage. J Exp Med (1997) 1.67
High-dose/activation-associated tolerance: a mechanism for allograft tolerance. Transplantation (1997) 1.65
A short course of methylprednisolone immunosuppression inhibits both rejection and spontaneous acceptance of rat liver allografts. Transplantation (2001) 1.61
Does alcohol directly stimulate pancreatic fibrogenesis? Studies with rat pancreatic stellate cells. Gastroenterology (2000) 1.55
CD26: a multifunctional integral membrane and secreted protein of activated lymphocytes. Scand J Immunol (2001) 1.53
Antigen-specific primary activation of CD8+ T cells within the liver. J Immunol (2001) 1.47
Multiple endoscopies in a Sydney blood donor found positive for hepatitis B and C antibodies. Med J Aust (1996) 1.40
Cloning, expression and chromosomal localization of a novel human dipeptidyl peptidase (DPP) IV homolog, DPP8. Eur J Biochem (2000) 1.32
A single beta-globin locus control region element (5' hypersensitive site 2) is sufficient for developmental regulation of human globin genes in transgenic mice. Mol Cell Biol (1992) 1.29
Characterization of the human homolog of the rat MRC OX-2 membrane glycoprotein. Immunogenetics (1987) 1.24
Long-term survival with tumor regression in androgen-induced liver tumors. Cancer (1985) 1.23
Risk of diabetes-related amputation in South Asians vs. Europeans in the UK. Diabet Med (2002) 1.21
Intrahepatic hepatitis C RNA levels do not correlate with degree of liver injury in patients with chronic hepatitis C. Hepatology (1996) 1.19
The gene for MRC OX-2 membrane glycoprotein is localized on human chromosome 3. Immunogenetics (1987) 1.18
False detection of negative-strand hepatitis C virus RNA. Lancet (1994) 1.18
Diabetes and nonalcoholic Fatty liver disease: a pathogenic duo. Endocr Rev (2012) 1.18
Transmission of hepatitis C virus to infants of human immunodeficiency virus-negative intravenous drug-using mothers: rate of infection and assessment of risk factors for transmission. J Viral Hepat (1997) 1.14
Molecular pathogenesis of liver disease: an approach to hepatic inflammation, cirrhosis and liver transplant tolerance. Immunol Rev (2000) 1.11
Inflammatory pseudotumor of the liver causing biliary obstruction. Treatment by biliary stenting with 5-year follow-up. J Clin Gastroenterol (1991) 1.09
Two highly conserved glutamic acid residues in the predicted beta propeller domain of dipeptidyl peptidase IV are required for its enzyme activity. FEBS Lett (1999) 1.09
Evidence that portal tract microvascular destruction precedes bile duct loss in human liver allograft rejection. Transplantation (1993) 1.08
Genomic organization, exact localization, and tissue expression of the human CD26 (dipeptidyl peptidase IV) gene. Immunogenetics (1994) 1.06
Combination low-dose hepatitis B immune globulin and lamivudine therapy provides effective prophylaxis against posttransplantation hepatitis B. Liver Transpl (2000) 1.04
Liver transplantation for HCV-associated liver cirrhosis: predictors of outcomes in a population with significant genotype 3 and 4 distribution. Liver Transpl (2003) 1.03
Sheep MHC class II molecules. I. Immunochemical characterization. Immunology (1987) 1.03
Iatrogenic incarceration of umbilical hernia in cirrhotic patients with ascites. Am J Gastroenterol (1995) 1.02
Neuronal/lymphoid membrane glycoprotein MRC OX-2 is a member of the immunoglobulin superfamily with a light-chain-like structure. Biochem Soc Symp (1986) 1.02
Increased intrahepatic messenger RNA expression of interleukins 2, 6, and 8 in human cirrhosis. Gastroenterology (1994) 1.02
A foot care program for diabetic unilateral lower-limb amputees. Diabetes Care (2001) 1.01
Deletion of spontaneous rat liver allograft acceptance by donor irradiation. Transplantation (1995) 1.00
Sequential increases in the intrahepatic expression of epidermal growth factor, basic fibroblast growth factor, and transforming growth factor beta in a bile duct ligated rat model of cirrhosis. Hepatology (1997) 0.98
Evidence that apoptosis of activated T cells occurs in spontaneous tolerance of liver allografts and is blocked by manipulations which break tolerance. Transplantation (1999) 0.97
Bone loss after liver transplantation. Hepatology (1991) 0.97
Is paraoxonase related to atherosclerosis. Chem Biol Interact (1993) 0.96
The heterogeneity of bone disease in cirrhosis: a multivariate analysis. Osteoporos Int (2003) 0.96
Early up-regulation of macrophages and myofibroblasts: a new marker for development of chronic renal allograft rejection. Transplantation (2000) 0.95
Identification of the bile canalicular cell surface molecule GP110 as the ectopeptidase dipeptidyl peptidase IV: an analysis by tissue distribution, purification and N-terminal amino acid sequence. Hepatology (1990) 0.95
An analysis of dynamic forces transmitted through the foot in diabetic neuropathy. Diabetes Care (1998) 0.93
Mutations in the hepatitis B virus precore/core gene and core promoter in patients with severe recurrent disease following liver transplantation. Hepatology (1996) 0.93
Incretin-based therapies--review of the physiology, pharmacology and emerging clinical experience. Intern Med J (2011) 0.93
Spontaneous clearance of hepatitis C virus infection post-liver transplantation is associated with rapidly changing quasispecies: a single case report. Liver Transpl (2000) 0.93
Comparison of de novo cancer incidence in Australian liver, heart and lung transplant recipients. Am J Transplant (2012) 0.93
Ethanol-induced alterations in messenger RNA levels correlate with glandular content of pancreatic enzymes. J Lab Clin Med (1995) 0.92
Regulation of human fetal and adult globin genes in mouse erythroleukemia cells. Blood (1991) 0.92
Specific in vitro antibody responses by human blood lymphocytes: apparent nonresponsiveness of PBL is due to a lack of recirculating memory B cells. J Immunol (1982) 0.92
Human antigen-specific IgA responses in blood and secondary lymphoid tissue: an analysis of help and suppression. J Immunol (1984) 0.91
Allele non-amplification: a source of confusion in linkage studies employing microsatellite polymorphisms. Hum Mol Genet (1993) 0.91
Tolerance to rat liver allografts. III. Donor cell migration and tolerance-associated cytokine production in peripheral lymphoid tissues. J Immunol (1996) 0.91
Intrahepatic expression of the hepatic stellate cell marker fibroblast activation protein correlates with the degree of fibrosis in hepatitis C virus infection. Liver (2002) 0.91
Cytochrome P4502E1 is present in rat pancreas and is induced by chronic ethanol administration. Gut (1998) 0.91
Expression of the rat CD26 antigen (dipeptidyl peptidase IV) on subpopulations of rat lymphocytes. Cell Immunol (1991) 0.90
Primary graft dysfunction after liver transplantation. Transplant Proc (2000) 0.88
Kinetics of intragraft cytokine expression, cellular infiltration, and cell death in rejection of renal allografts compared with acceptance of liver allografts in a rat model: early activation and apoptosis is associated with liver graft acceptance. Transplantation (1998) 0.88
Cholestatic hepatitis after liver transplantation is associated with persistently high serum hepatitis C virus RNA levels. Liver Transpl Surg (1998) 0.88
Giant cavernous haemangioma: a rare indication for liver transplantation. Aust N Z J Surg (1996) 0.88
Post-transplant quasispecies pattern remains stable over time in patients with recurrent cholestatic hepatitis due to hepatitis C virus. J Hepatol (2000) 0.88
Post-proline-cleaving peptidases having DP IV like enzyme activity. Post-proline peptidases. Adv Exp Med Biol (2000) 0.87
Donor portal vein arterialization during liver transplantation. Transplant Proc (1989) 0.87
Quantitative reverse transcriptase-PCR amplification of cytokine mRNA in liver biopsy specimens using a non-competitive method. Immunol Cell Biol (1997) 0.87
Cysticercosis: cellular immune responses during primary and secondary infection. Parasite Immunol (1990) 0.87
Striking variability of hepatic copper levels in fulminant hepatic failure. J Gastroenterol Hepatol (1992) 0.87
Hepatitis B virus precore mutant infection is associated with severe recurrent disease after liver transplantation. Hepatology (1995) 0.87
Peripheral vascular and nerve function associated with lower limb amputation in people with and without diabetes. Clin Sci (Lond) (2001) 0.87
Nodular regenerative hyperplasia mimicking cirrhosis of the liver. Gut (1990) 0.86
Orthotopic liver transplantation for treatment of patients with Budd-Chiari syndrome: a Singe-center experience. Transplant Proc (2000) 0.86
Binding to human dipeptidyl peptidase IV by adenosine deaminase and antibodies that inhibit ligand binding involves overlapping, discontinuous sites on a predicted beta propeller domain. Eur J Biochem (1999) 0.86
Fulminant hepatic failure and liver transplantation. Transplant Proc (1992) 0.86
Experimental autoimmune cholangitis: a mouse model of immune-mediated cholangiopathy. Liver (2000) 0.85
Soluble CD26 / dipeptidyl peptidase IV enhances human lymphocyte proliferation in vitro independent of dipeptidyl peptidase enzyme activity and adenosine deaminase binding. Scand J Immunol (2011) 0.85
Vascular endothelial growth factor expression in human chronic renal allograft rejection. Transplantation (1999) 0.85
Tolerance to rat liver allografts. I. Differences between tolerance and rejection are more marked in the B cell compared with the T cell or cytokine response. Transplantation (1994) 0.85
Detection of serum hepatitis C virus RNA in HCV antibody-seropositive volunteer blood donors. Hepatology (1993) 0.85
De novo cancer-related death in Australian liver and cardiothoracic transplant recipients. Am J Transplant (2013) 0.85
Hypothalamic-pituitary adrenal function in end-stage non-alcoholic liver disease. J Gastroenterol Hepatol (1993) 0.84